Efficacy and safety of cinepazide maleate injection in patients with acute ischemic stroke: a multicenter, randomized, double-blind, placebo-controlled trial

BACKGROUND: Ischemic stroke is a leading cause of morbidity and mortality. Thrombolytic therapy improves disability and survival rates; however, to be effective, it must be given within 4.5 h of onset. Moreover, thrombolytic therapy is frequently contraindicated. Therefore, alternative therapeutic o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Jun, Chen, Huisheng, Chen, Guofang, Ji, Yong, Yi, Fei, Zhang, Zhuobo, Yang, Yi, Wu, Jin, Cai, Xueli, Shao, Bei, Wang, Jianfeng, Liu, Yafang, Geng, Deqin, Qu, Xinhui, Li, Xiaohong, Wei, Yan, Ding, Jianping, Lü, Hua, Huang, Yining, Huang, Yonghua, Xiao, Bo, Gong, Tao, Cui, Liying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359492/
https://www.ncbi.nlm.nih.gov/pubmed/32664877
http://dx.doi.org/10.1186/s12883-020-01844-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359492/
https://www.ncbi.nlm.nih.gov/pubmed/32664877
http://dx.doi.org/10.1186/s12883-020-01844-8

Ejemplares similares